Clinical Trials Logo

Clinical Trial Summary

The goal of this experimental medicine study is to examine the effect of increasing serotonin on reward processing in healthy volunteers. The main questions it aims to answer are: 1. Does a subacute increase in serotonin influence the activation regions during reward learning 2. Does a subacute increase in serotonin influence behavioural markers of reward valuation (effort task), responsiveness (taste task) and learning (learning task) Participants will be: given a 7-day course of the selective serotonin reuptake inhibitor, citalopram. undergo behavioural testing complete a reward learning task whilst undergoing fMRI Researchers will compare results against a placebo group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06017037
Study type Interventional
Source University of Oxford
Contact Alexander Smith, MBBS
Phone 07865 618318
Email alexander.smith@psych.ox.ac.uk
Status Recruiting
Phase Phase 1/Phase 2
Start date May 19, 2023
Completion date May 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Enrolling by invitation NCT06035562 - Promoting Positive Emotional Functioning in Police and Military Populations N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Completed NCT03043560 - Study to Treat Major Depressive Disorder With a New Medication Phase 2
Withdrawn NCT05507385 - Imagine a Brighter Future: An Intervention to Improve Positive Emotions in Young People N/A
Completed NCT05383248 - Computational Cognitive Training To Boost Reward Responsiveness In Anhedonic Patients N/A
Suspended NCT03715400 - Mobile Virtual Positive Experiences for Anhedonia N/A
Recruiting NCT05240352 - Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression N/A
Recruiting NCT03915613 - Brain Insulin Resistance in Mood Disorders Phase 1/Phase 2
Completed NCT04121091 - Pramipexole to Target "Anhedonic Depression" Phase 2
Completed NCT03939676 - Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity
Enrolling by invitation NCT06285474 - Investigating LIFUP in Anhedonic Depression N/A
Recruiting NCT05870501 - Synaptic Imaging and Network Activity in Treatment Resistant Depression N/A
Active, not recruiting NCT03848715 - Sleep and Healthy Aging Research on Depression for Younger Women Phase 1
Completed NCT05165394 - Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD Phase 2
Completed NCT04647019 - The Effects of Wild Blueberries on Depressive Symptoms in Young Adults N/A
Recruiting NCT06075771 - Dopaminergic Therapy for Anhedonia - 2 Phase 4
Completed NCT02958228 - The Effect of Computerized Cognitive Training on Mood and Thinking Style Amongst Patients in Inpatient Settings N/A
Recruiting NCT05991713 - Geolocation Positional System (GPS) Experience N/A
Completed NCT05084924 - Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia N/A